Article
Only 10 percent of PSORS1 carriers affectedPhysician: James T. Elder, M.D., Ph.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Hyaluronic Acid Boosts Results in Rosacea Management
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
FDA Places Clinical Hold on VYNE’s VYN202 Phase 1b Trial for Plaque Psoriasis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Stopping Adjuvant Immunotherapy Early May Not Worsen Outcomes in Resected Metastatic Melanoma
Novel Microneedle Radiofrequency Device is Safe for Horizontal Neck Wrinkles